Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32

Stat6 Signaling Suppresses VLA-4 Expression by CD8+ T Cells and Limits Their Ability to Infiltrate Tumor Lesions In Vivo

(2014) K. Sasaki et al.   JOURNAL OF IMMUNOLOGY

Endogenous IL-32 Controls Cytokine and HIV-1 Production

(2014) M. F. Nold et al.   JOURNAL OF IMMUNOLOGY

Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice

(2014) J.-I. Youn et al.   JOURNAL OF IMMUNOLOGY

Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expressionof interleukin-32 controls the expression of the humanpapillomavirus oncogene

(2011) Sojung Lee et al.   IMMUNOLOGY

Protection from RNA and DNA Viruses by IL-32

(2011) Jarod A. Zepp et al.   JOURNAL OF IMMUNOLOGY

Inflammation-dependent secretion and splicing of IL-32  in rheumatoid arthritis

(2011) B. Heinhuis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis

(2010) Norbert Meyer et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Intralesional Delivery of Dendritic Cells Engineered to Express T-bet Promotes Protective Type 1 Immunity and the Normalization of the Tumor Microenvironment

(2010) Y. Qu et al.   JOURNAL OF IMMUNOLOGY

Interleukin-32β Propagates Vascular Inflammation and Exacerbates Sepsis in a Mouse Model

(2010) Hanako Kobayashi et al.   PLoS One

Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity

(2009) H Komita et al.   CANCER GENE THERAPY

The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies

(2009) J. Ozao-Choy et al.   CANCER RESEARCH

Molecular characterization of IL-32 in human endothelial cells

(2009) Hanako Kobayashi et al.   CYTOKINE

Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites

(2009) Steven A. Saenz et al.   IMMUNOLOGICAL REVIEWS

Interleukin-32 Expression in the Pancreas

(2009) Atsushi Nishida et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

COX-2, VEGF and tumour angiogenesis

(2009) D.P. Toomey et al.   SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND

IL-32, a Novel Proinflammatory Cytokine in Chronic Obstructive Pulmonary Disease

(2008) Fiorella Calabrese et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

CD8+ T-Cell Responses against Hemoglobin-  Prevent Solid Tumor Growth

(2008) H. Komita et al.   CANCER RESEARCH

Cancer Immunotherapy by Dendritic Cells

(2008) Cornelis J.M. Melief   IMMUNITY

Activation of Interleukin-32 Pro-Inflammatory Pathway in Response to Influenza A Virus Infection

(2008) Wei Li et al.   PLoS One

Interleukin-32 induces the differentiation of monocytes into macrophage-like cells

(2008) M. G. Netea et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA